Literature DB >> 11343039

Children's school performance is not impaired by short-term administration of diphenhydramine or loratadine.

B G Bender1, D R McCormick, H Milgrom.   

Abstract

OBJECTIVE: The purpose of this study was to determine whether a second-generation H1 antihistamine produces less sedation in children and permits greater learning in a school setting than a classic antihistamine. STUDY
DESIGN: Sixty-three 8- to 10-year-old children who had histories of seasonal allergic rhinitis but had no symptoms at the time of the study were randomly assigned to 1 of 3 treatment groups: placebo, diphenhydramine, or loratadine. Medications were administered on 3 of 4 study days, twice 6 hours apart, while participants attended a laboratory school. Classroom testing at the end of each school day evaluated the children's retention of curriculum material. Potential sedative effects were additionally evaluated by self-report of somnolence and computerized reaction-time testing.
RESULTS: No treatment-related differences emerged on the verbal instruction score, reading test score, reaction time, or somnolence scale.
CONCLUSIONS: Learning and response time in children attending a laboratory school were not significantly affected by either antihistamine.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11343039     DOI: 10.1067/mpd.2001.112647

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  2 in total

Review 1.  Second-generation antihistamines: actions and efficacy in the management of allergic disorders.

Authors:  Larry K Golightly; Leon S Greos
Journal:  Drugs       Date:  2005       Impact factor: 9.546

2.  Treatment of allergic rhinitis in infants and children: efficacy and safety of second-generation antihistamines and the leukotriene receptor antagonist montelukast.

Authors:  Hanna Phan; Matthew L Moeller; Milap C Nahata
Journal:  Drugs       Date:  2009       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.